Acceler8 Clinical Research announces the opening of new office in Knutsford, Cheshire.
Acceler8 Clinical Research is delighted to announce the opening of their new office at Booths Hall, Knutsford as a result of continued European expansion. The office will provide a co-operative workspace for Acceler8 Clinical Research’s independent quality assurance division, The CQA Company, along with the company’s UK-based operational staff.
Acceler8 Clinical Research, which acquired The CQA Company in 2019, has achieved steady growth throughout the pandemic, and the Quality Assurance team has grown accordingly.
Ceri Thornley, QA Manager explained Acceler8 Clinical Research’s choice of location. “The CQA Company delivers its services internationally, and UK clients account for a significant proportion of requests for our CQA services. We look forward to welcoming our clients to the new office in due course.”
Tom Richardson, A8CR’s General Manager added “we are excited to open the office at Booths Hall as part of our growth strategy for 2022. Following the successful implementation of a home-working policy in 2020, we are delighted to once again offer our team and clients a communal space for collaborative projects.”
Booths Hall, Knutsford
About Acceler8 Clinical Research
Acceler8 Clinical Research is a trading name of The Pharmaceutical Code Company Limited, a privately owned, full-service contract research organisation, helping pharmaceutical manufacturers and research organisations to successfully bring their products to market. The CQA Company is Acceler8 Clinical Research’s independent Quality Assurance division. The CQA Company has delivered clinical quality assurance services, including GMP, GCP, GLP, GDP and GPvP audits and consultancy globally, since 2002.